Supernus Pharmaceuticals | SUPN - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Abbott USD 2.13B 281M 2026-06
ANI Pharmaceuticals USD 39.84M 1.13M 2026-06
Aurora Cannabis CAD -10.03M 25.76M 2026-03
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Canopy Growth CAD -27.47M 14.81M 2026-03
Cara Therapeutics USD -7.05M 1.11M 2026-03
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Eisai JPY 24.73B 35.04B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Novo Nordisk DKK 33.76B 25.86B 2026-06
Pacira USD 9.96M 5.33M 2026-06
Perrigo USD 23.5M 10.1M 2026-06
Pfizer USD 667M 4.32B 2026-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
United Therapeutics USD 330.8M 5M 2026-06
Xeris Pharmaceuticals USD 7.92M 8.86M 2026-03